General Considerations for Pediatric Formulation Development: Setting Target Product Profiles

Read full text
Authors: Daniel Schaufelberger
Cited by: 1
References: 2

Abstract

Developing new drugs for children and the corresponding age-appropriate dosage forms and formulations are complex tasks. In this chapter, we describe the use of a simple but powerful methodology: developing a Pediatric Quality Target Product Profile (ped QTPP) to generate focus and clarity for the product to be developed. In this context, “Quality” is a synonym for “Chemistry, Manufacturing, and Controls” (CMC). A proposal for structure and content of the ped QTPP is provided, as well as suggestions on how this “living document” can be used by the formulation scientists and project teams to guide compound development strategies and plans.

Fields of Study & Subjects

Pharmaceutical studies and practices Pharmaceutical Economics and Policy Statistical Methods in Clinical Trials

Publication details

Journal / source
AAPS advances in the pharmaceutical sciences series
Publisher
Springer Nature Switzerland
Pages
33–45
Publication date
1 January 2026
Language
EN
Document type
Book chapter